Bio Break: Achieving a 20-Year Resolution – Biofilm Testing Standard

Resources

Bio Break: Achieving a 20-Year Resolution – Biofilm Testing Standard

Sector: Diagnostics
Topic: Bio Break

In this special New Year’s episode of Bio Break, Joris van der Heijden and Nick Allan reflect on resolutions, persistence, and a 20-year journey to establish a new standard for biofilm testing in medical devices.

Nick shares the story of his two-decade-long mission to develop a standardized test method for growing and monitoring biofilm on medical device surfaces. This effort, initiated through the ASTM E35 Committee (American Standard Test Method Organization), recently culminated in the release of ASTM Standard E3435. This method enables researchers and developers to evaluate biofilm growth and assess the effectiveness of materials designed to inhibit or prevent biofilm formation—an essential consideration in medical device development.

Nick showcases a prototype from 20 years ago that played a critical role in this process. The device uses loops of various catheter materials, some treated with antimicrobial agents, to test biofilm growth under controlled conditions. This tool allows developers to measure the performance of materials against biofilm formation, offering a reliable way to test and improve medical devices.

Key takeaways from the episode include:

  • The importance of standardized testing in ensuring the safety and efficacy of medical devices.
  • How the ASTM E3435 standard supports innovation by providing consistent methods for evaluating biofilm interactions with materials.
  • The value of persistence and long-term vision in bringing impactful projects to fruition.

This episode highlights the critical role of biofilm testing in advancing medical devices and the dedication required to turn a passion for innovation into a tangible outcome.

Whether you’re a medical device developer, materials scientist, or healthcare professional, this episode offers valuable insights into the process of creating industry standards that drive innovation and improve patient outcomes.

Achieving a 20-Year Resolution – Biofilm Testing Standard

Brain-computer interface - A man wearing a brain-computer interface (BCI) headset sits in a clinical setting, concentrating as he appears to control a robotic arm with his mind. His head is overlaid with digital graphics representing brain activity. A doctor in a white lab coat stands nearby, monitoring the interaction. Onscreen data displays in the background suggest medical or neurological analysis. Bold text on the image reads "Brain-Controlled Tech?"

We explore the world of brain-computer interfaces (BCIs) and the challenges of capturing thought into action. Mark Drlik and Ariana Wilson walk through how these systems translate brain activity into control signals for devices—without needing surgical implants.

Person applying a white microneedle patch to their upper arm, with a red arrow pointing to the patch and a close-up of the microneedles on the right. Text reads “Painless!” to highlight the pain-free nature of the patch.

Nigel and Nick explore microneedle drug delivery—a growing field in medtech that aims to improve patient comfort and treatment compliance. While the term “microneedles” may sound futuristic, this technology has been around for years.

A 3D computational fluid dynamics (CFD) simulation result showing a scalar field contour in a branched tube system, with values ranging from 0.000 (blue) to 0.500 (red). The contour visualization highlights flow variation along the geometry, with red and orange indicating high scalar values in upper segments and blue-green regions representing lower values in the lower tube segments.

The impact of shear stress is critical to effectively design medical devices that handle biological fluids such as proteins or cell culture media. For example, non-physiological shear stress (NPSS) on blood is a key factor because hemolysis (cell rupture) could occur due to accumulated stress.